BioAtla Inc. (BCAB) PT Raised to $8 at Credit Suisse
Tweet
Share
E-mailGet Alerts BCAB Hot Sheet
Price: $3.30 -4.35%
Rating Summary:
5 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 11
Rating Summary:
5 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 11
Join SI Premium – FREE
Credit Suisse analyst Tiago Fauth raised the price target on BioAtla Inc. (NASDAQ: BCAB) to $8.00 (from $4.00) while maintaining a Neutral rating.
You May Also Be Interested In
- CIBC Upgrades PRO REIT (PRV-U:CN) to Outperformer
- Intuitive Machines Inc. (LUNR) PT Lowered to $32 at Cantor Fitzgerald, Reaffirms Overweight Rating
- Thai Oil (TOP:TB) (TOIPY) PT Raised to THB74 at Goldman Sachs
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
